FDA Approves First Nasal Spray for Anaphylaxis Treatment

By Richard Waithe, PharmD
FDA Approves First Nasal Spray for Anaphylaxis Treatment
Drug Safety & RecallsFDA ApprovalsTech

Related Articles

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management
Clinical Practice

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss
Clinical Practice

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know
Clinical Practice

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know